Overview of the global liver disease treatment market

According to Technavio’s market research report, the global liver disease treatment market will grow at a CAGR of more than 11% during the forecast period. One of the key factors that will drive market’s growth during the forecast period is the rising prevalence of alcohol-related liver disease. The liver plays a major role in removing toxins and impurities such as alcohol from the blood. The cells of the liver are destroyed each time it processes the alcohol content in the body. Continuous exposure to heavy alcohol can damage the liver making it difficult for the cells to regenerate. This can result in liver cirrhosis and even death in severe cases. According to NIH, an estimated 88,000 people succumb to alcohol-related illnesses every year. It has been observed that the consumption of alcohol is increasing in developing economies such as India. In India, more than one fourth of citizens consume alcohol. The hazardous drinking habits of the population of south Asian countries will increase the prevalence of alcohol related liver problems, boosting the demand for alcohol related liver disease treatments.

The Americas contributed to the maximum market shares during 2016 due to the presence of major players in this region. The market will continue to grow in the region in the forthcoming years due to the increased investment in R&D activities by the governments of various countries. Furthermore, the increasing prevalence of lifestyle disorders such as diabetes and obesity will drive the risk of liver disease in the region, boosting the need for liver disease treatments in the liver transplant market.

Competitive landscape and key vendors

The liver disease treatment market is characterized by the presence of leading players. These vendors are increasingly competing against each other based on factors such as aggressive pricing and new indications. Large vendors in the liver transplant market are collaborating with small and mid-sized vendors to develop better drugs. Additionally, they are also focusing on expanding their product portfolio and enhancing their geographical footprints by adopting strategic collaborations.

Key vendors in this market are -

• F. Hoffmann-la Roche
• Gilead
• GlaxoSmithKline
• Merck

Other prominent vendors in the market include Bristol-Myers Squibb, Johnson and Johnson, Novartis, Salix Pharmaceuticals, and Vertex Pharmaceuticals.

Segmentation by drug class and analysis of the liver disease treatment market

• Corticosteroids
• Anti-viral
• Vaccines

Hepatitis is a major liver disease that can be both viral and non-viral. Anti-viral drugs are highly preferred for the treatment of viral hepatitis as they inhibit the growth of target pathogens. Hepatitis A, B, and C are the most common types of viral infections. Anti-viral drugs are also used to treat HIV, herpes, and influenza. The sales volume of direct-acting antiviral drugs such as Gilead's Harvoni and Sovaldi will increase during the predicted period in the liver transplant market since they have the ability to treat all strains of the hepatitis virus.

Segmentation by disease type and analysis of the liver disease treatment market

• ARLD
• NAFLD
• Hepatitis
• PBC
• Hemochromatosis

The alcohol related liver disease (ARLD) is caused due to the overconsumption of alcohol and is a hepatic manifestation. The symptoms for ARLD include weight loss, loss of appetite, jaundice, drowsiness, swelling in the abdomen and ankles, and the passing of blood in the stool or vomiting blood. These symptoms are visible only when the liver has been severely damaged. ARLD can result in internal bleeding, encephalopathy or build-up of toxins in the brain, and kidney failure, which in turn, will drive the demand for ARLD drugs or liver disease.

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global liver disease treatment market?
• What are the key market trends impacting the growth of the global liver disease treatment market?
• What are the challenges to market growth?
• Who are the key vendors in the global liver disease treatment market?
• What are the market opportunities and threats faced by the vendors in the global liver disease treatment market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global liver disease treatment market?

Technavio also offers customization on reports based on specific client requirement